Tenet Healthcare Corp THC
We take great care to ensure that the data presented and summarized in this overview for TENET HEALTHCARE CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding THC
View all-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.31 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY9.88MShares$1.28 Billion0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.47MShares$967 Million0.14% of portfolio
-
Invesco Ltd. Atlanta, GA5.04MShares$653 Million0.17% of portfolio
-
State Street Corp Boston, MA2.91MShares$376 Million0.02% of portfolio
-
Glenview Capital Management, LLC New York, NY2.66MShares$344 Million8.56% of portfolio
-
Geode Capital Management, LLC Boston, MA2.04MShares$265 Million0.03% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA1.82MShares$235 Million0.25% of portfolio
-
Bank Of America Corp Charlotte, NC1.7MShares$220 Million0.02% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL1.65MShares$214 Million0.08% of portfolio
Latest Institutional Activity in THC
Top Purchases
Top Sells
About THC
Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb-salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, and telemedicine access services. In addition, it operates ambulatory surgery and urgent care centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals; and offers healthcare business process services in the areas of hospital and physician revenue cycle management, patient communications and engagement support, and value-based care solutions to hospitals, health systems, physician practices, employers, and other customers. As of February 09, 2022, the company operated 60 hospitals; and approximately 550 other healthcare facilities, including surgical hospitals, ambulatory surgery centers, urgent care and imaging centers, and other care sites and clinics. Tenet Healthcare Corporation was incorporated in 1975 and is headquartered in Dallas, Texas.
Insider Transactions at THC
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 31
2024
|
Lisa Y Foo EVP, Commercial Ops |
SELL
Open market or private sale
|
Direct |
4,000
-10.5%
|
$620,000
$155.88 P/Share
|
Sep 05
2024
|
R. Scott Ramsey Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
11,599
-64.72%
|
$1,879,038
$162.06 P/Share
|
Aug 27
2024
|
Richard W Fisher |
SELL
Open market or private sale
|
Direct |
2,000
-6.36%
|
$326,000
$163.72 P/Share
|
Aug 16
2024
|
Paola M Arbour EVP, Chief Information Officer |
SELL
Open market or private sale
|
Direct |
8,377
-28.11%
|
$1,306,812
$156.0 P/Share
|
Aug 15
2024
|
Saumya Sutaria Chairman & CEO |
SELL
Open market or private sale
|
Indirect |
13,773
-94.44%
|
$2,121,042
$154.93 P/Share
|
Aug 14
2024
|
Saumya Sutaria Chairman & CEO |
SELL
Open market or private sale
|
Indirect |
86,227
-54.12%
|
$13,278,958
$154.88 P/Share
|
Aug 06
2024
|
Meghan Fitzgerald |
SELL
Open market or private sale
|
Direct |
20,000
-56.71%
|
$2,920,000
$146.34 P/Share
|
Jun 10
2024
|
Saumya Sutaria Chairman & CEO |
BUY
Bona fide gift
|
Indirect |
100,000
+50.0%
|
-
|
Jun 10
2024
|
Saumya Sutaria Chairman & CEO |
SELL
Bona fide gift
|
Direct |
100,000
-26.92%
|
-
|
Jun 10
2024
|
Richard W Fisher |
SELL
Open market or private sale
|
Direct |
1,400
-7.94%
|
$184,800
$132.24 P/Share
|
May 31
2024
|
J Robert Kerrey |
SELL
Open market or private sale
|
Indirect |
9,500
-92.86%
|
$1,273,000
$134.3 P/Share
|
May 30
2024
|
J Robert Kerrey |
BUY
Bona fide gift
|
Indirect |
9,500
+50.0%
|
-
|
May 30
2024
|
J Robert Kerrey |
SELL
Bona fide gift
|
Direct |
9,500
-20.47%
|
-
|
May 30
2024
|
J Robert Kerrey |
SELL
Open market or private sale
|
Direct |
14,322
-12.56%
|
$1,904,826
$133.92 P/Share
|
May 30
2024
|
Christopher S. Lynch |
SELL
Open market or private sale
|
Direct |
10,861
-42.39%
|
$1,444,513
$133.83 P/Share
|
May 09
2024
|
Nadja West |
SELL
Open market or private sale
|
Direct |
1,782
-5.66%
|
$224,532
$126.41 P/Share
|
May 07
2024
|
Richard W Fisher |
SELL
Open market or private sale
|
Direct |
2,500
-12.42%
|
$307,500
$123.2 P/Share
|
May 01
2024
|
Thomas W Arnst EVP, Chief Admin. Officer & GC |
SELL
Open market or private sale
|
Direct |
8,148
-50.53%
|
$945,168
$116.85 P/Share
|
Apr 05
2024
|
Saumya Sutaria Chairman & CEO |
SELL
Bona fide gift
|
Direct |
125,000
-25.18%
|
-
|
Mar 12
2024
|
Richard J Mark |
SELL
Open market or private sale
|
Direct |
14,000
-29.6%
|
$1,372,000
$98.98 P/Share
|
Last 12 Months Summary
Bona fide gift | 110K shares |
---|---|
Grant, award, or other acquisition | 170K shares |
Exercise of conversion of derivative security | 149K shares |
Open market or private sale | 254K shares |
---|---|
Bona fide gift | 235K shares |
Payment of exercise price or tax liability | 147K shares |